- Press Release -

Rockville, Md. The global neurointerventional devices market is set for healthy growth through 2022, according to Fact.MR, as rising rates of atherosclerosis and ischemic stroke push demand for less invasive treatment. Clinicians increasingly favour catheter-based approaches to vascular disorders of the spine, neck and head, and that preference is reshaping the device mix.

North America leads the market, embolic coils are the top-selling product, and hospitals handle the most procedures. The coiling procedure dominates by technology, with balloons the fastest-growing device line.

Products, Procedures and Settings

Embolic coils outsell other devices and are set at over US$ 270 Mn in 2017, with neurovascular thrombectomy the next-largest product by revenue and balloons posting a relatively high CAGR. By technology, the coiling procedure leads at over US$ 300 Mn in 2017, followed by neurothrombectomy at over US$ 100 Mn, while stenting, cerebral angiography and coiling grow at similar, high rates. On settings, hospitals are the leading end user at over US$ 900 Mn by 2022 and grow fastest, with ambulatory surgical centers second.

North America is the major region, supported by strong clinical infrastructure and high procedure volumes.

Minimally Invasive Care Drives Demand

The market's momentum comes from a clear clinical shift. As physicians and patients favour minimally invasive procedures that shorten recovery and reduce risk, demand for neurointerventional devices climbs, and the growing burden of vascular disease widens the pool of treatable cases through the forecast period.

Suppliers and Their Playbook

The field brings together large device and neuromodulation specialists.

• Medtronic plc, Boston Scientific Corporation, Nevro Corp., St. Jude Medical, Inc., Stimwave Technologies, Inc., Saluda Medical Pty Ltd., and Nuvectra Corporation are among the key players in the report.

Reading the Market for Decisions

For device makers, growth favours coil and balloon platforms and hospital-focused sales. Investors get a market with a firm clinical tailwind. Procurement and hospital teams can plan around embolic coils and the coiling procedure carrying volume, hospitals leading demand, and North America offering the largest opportunity through 2022.

About the Report

Fact.MR's study covers the global neurointerventional devices market for the 2017 to 2022 forecast period, with segmentation by product, technology, end user and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the neurointerventional devices market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.